Dr. Reddy’s Laboratories through its wholly owned subsidiary -- Promius Pharma, LLC has declared the sale of its rights for SERNIVO (betamethasone dipropionate) Spray, 0.05% and assignment of its rights to market and distribute, PROMISES Topical Cream and TRIANEX 0.05% (Triamcinolone Acetonide Ointment, USP) in the United States, to Encore Dermatology.
Under the terms of the agreement, Promius Pharma is eligible to receive an upfront payment and future milestone payments contingent upon achievement of certain commercial objectives.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
